Alere has issued a voluntary correction to users of the Alere INRatio and INRatio 2 PT/INR Monitor system of certain medical conditions that should not be tested with the system (INRatio Monitor ...

WALTHAM, Mass., Dec. 8, 2014 /PRNewswire/ -- Alere Inc. has initiated a voluntary correction to inform U.S. users of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitor system of certain medical ...

Alere has announced a voluntary withdrawal of the Alere INRatio and INRatio 2 PT/INR Monitoring System. Alere has announced a voluntary withdrawal of the Alere INRatio and INRatio 2 PT/INR Monitoring ...

INDIANAPOLIS, March 19 /PRNewswire/ -- Medicare Part B will now cover and pay for meter training, equipment and supplies for all long-term warfarin users who monitor their prothrombin time at home ...

Concerned over nine serious adverse events, three of which described bleeding associated with patient deaths, Alere Inc. of Waltham, MA issued a voluntary urgent recall of its PN 99008G2 INRatio2 ...

FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense ® PT/INR ...